XCellerate安全报告

XCellerate安全报告increases your efficiency, productivity, compliance and quality of your pharmacovigilance and device vigilance operations across the clinical and post-marketing landscape.

Maximized Efficiency. Real-Time Collaboration. Improved Quality.

从数据收集到报告生成的自动化

Collaborative authoring and review based on RPA allows co-authoring, swift comments resolution

它会带来价值

XCellerate安全报告encompasses a portfolio of automation tools ranging from basic to AI-enabled, facilitating our minimal touch authoring vision. These tools eliminate manual processes, foster collaboration and review, facilitate swift comments resolution and ultimately automate data collection to report generation.

Overview

XCellerate安全报告包括RPA AI利用的安全性,医疗和监管报告创作解决方案,即建立最小触摸创作的能力。该工具提供了实时,开放和透明的数据聚合和中央在线数据库中的共享。

Benefits of Xcellerate Safety Reporting:

  • Maximized Efficiency. Real-Time Collaboration. Improved Quality.
  • Collaborative authoring and review based on RPA allows co-authoring, swift comments resolution
  • 从数据收集到报告生成的自动化
  • Real-time internal collaboration and content sharing/re-use improves turnaround time and quality
  • 自动生成报告部分提供增强的生产力

Dinesh Kashturil,Covance患者安全解决方案的全球客户总监在其最新的播客中与DIA Chris Slawecki讨论了讨论了当前和未来的药物检测状态(PV);以及技术和自动化如何用于推动PV连续体的运营效率。